Mercury Biopharmaceutical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 9, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	6,466	7,778	4,006	-	-	-
Market Cap Growth	-38.81%	94.15%	-	-	-	-
Enterprise Value	6,243	7,465	3,937	-	-	-
Last Close Price	15.60	18.70	9.87	-	-	-
PE Ratio	-	-175.10	-118.85	-	-	-
PS Ratio	1128.39	7530.00	1494.92	-	-	-
PB Ratio	19.96	20.03	22.22	-	-	-
P/FCF Ratio	-164.08	-141.24	-42.46	-	-	-
P/OCF Ratio	-231.90	-184.56	-155.03	-	-	-
EV/Sales Ratio	1107.59	7226.33	1469.06	-	-	-
EV/EBITDA Ratio	-150.58	-174.87	-135.05	-	-	-
EV/EBIT Ratio	-136.07	-163.38	-127.42	-	-	-
EV/FCF Ratio	-153.92	-135.55	-41.73	-	-	-
Debt / Equity Ratio	0.13	0.11	0.24	0.19	-1.44	150.00
Debt / FCF Ratio	-1.03	-0.77	-0.46	-0.17	-1.38	-0.76
Asset Turnover	0.01	0.00	0.02	-	-	-
Quick Ratio	20.07	41.33	19.79	1.50	0.28	0.98
Current Ratio	20.57	42.21	20.15	2.30	0.32	1.01
Return on Equity (ROE)	-11.79%	-15.41%	-32.76%	-103.62%	-	-
Return on Assets (ROA)	-6.98%	-8.55%	-15.87%	-49.14%	-103.35%	-
Return on Capital (ROIC)	-7.12%	-8.73%	-16.35%	-52.75%	-108.47%	-
Earnings Yield	-0.67%	-0.56%	-0.78%	-	-	-
FCF Yield	-0.63%	-0.71%	-2.36%	-	-	-
Buyback Yield / Dilution	-3.20%	-9.00%	-36.09%	-165.94%	-	-
Total Shareholder Return	-3.20%	-9.00%	-36.09%	-165.94%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.